诺禾致源 (688315.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.0x

Market Cap

CNY 7.05B

MomentumView details →

1D Return

+6.14%

YTD Return

—

RSI (14)

43.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.0x

Market Cap

CNY 7.05B

RSI (14)

43.2

MomentumView details →

1D Return

+6.14%

YTD Return

—

ProfitabilityView details →

Gross Margin

43.04%

Net Margin

7.18%

EBITDA Margin

14.39%

ROE (TTM)

6.07%

ROA (TTM)

4.24%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

+5.56%

EPS YoY

−19.92%

FCF YoY

−33.87%

Revenue CAGR 3Y

+4.69%

EPS CAGR 3Y

−2.33%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.08

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

2.62x

Quick Ratio

2.37x

Div Yield

0.32%

Div Rate

CNY 0.05

Div Growth 1Y

−10.00%

Financials snapshotView financials →

Revenue (TTM)

2.26B

Net Income (TTM)

162.52M

Op. CF (TTM)

246.90M

Latest newsMore news →

Novogene announced it will build its first local laboratory in Australia in partnership with Cabrini Health, located at Cabrini Malvern's clinical and cancer research campus in Melbourne, expected to open in 2027.7d ago

Novogene Co., Ltd. announced its semi-annual results for 2026, reporting a net profit attributable to shareholders of 63.1226 million yuan, down 19.82% year-on-year.10d ago

Similar companies

星湖科技600866.SH Rhythm Pharmaceuticals, Inc.RYTM Caris Life Sciences, Inc.CAI 昊海生科688366.SH Scholar Rock Holding CorporationSRRK Arcellx, Inc.ACLX Find similar companies →

Latest newsMore news →

Novogene announced it will build its first local laboratory in Australia in partnership with Cabrini Health, located at Cabrini Malvern's clinical and cancer research campus in Melbourne, expected to open in 2027.7d ago Novogene Co., Ltd. announced its semi-annual results for 2026, reporting a net profit attributable to shareholders of 63.1226 million yuan, down 19.82% year-on-year.10d ago